Study BMJ investigation on financial entanglements between FDA chiefs and the drug industry (May 2024) Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry

[Michael Harrop]

https://medicalxpress.com/news/2024-05-financial-entanglements-fda-chiefs-drug.html
https://www.bmj.com/content/385/bmj.q975

An investigation published by The BMJ today raises concerns about financial entanglements between US Food and Drug Administration (FDA) chiefs and the drug and medical device companies they are responsible for regulating.

The US Food and Drug Administration says that it takes conflicts of interest seriously. But financial entanglements with the drug industry are common among its leaders. Peter Doshi reports

Click to shrink...